Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Malcolm

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Vaccine|December 11, 1999
HPV6b virus like particles are potent immunogens without adjuvant in manL F Zhang, J Zhou, S Chen, et al.
Oncogene|September 6, 2011
An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancerA Mamo, L Cavallone, S Tuzmen, et al.
Pediatrics|July 3, 2004
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trialDouglas K Kelsey, Calvin R Sumner, Charles D Casat, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Vaccine|December 11, 1999
HPV6b virus like particles are potent immunogens without adjuvant in manL F Zhang, J Zhou, S Chen, et al.
Oncogene|September 6, 2011
An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancerA Mamo, L Cavallone, S Tuzmen, et al.
Pediatrics|July 3, 2004
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trialDouglas K Kelsey, Calvin R Sumner, Charles D Casat, et al.
Pageof 6